1. Cytochalasin B (10,ug/ml) enhances the release of rabbit polymorphonuclear leucocyte lysosomal acid hydrolases induced by retinol (vitamin A alcohol). 2. This effect is seen at doses of the vitamin that cause selective release of acid hydrolases and those causing more general enzyme release indicated by the loss of lactate dehydrogenase. 3. Cytochalasin B (2-50,ug/ml) has no effect on the release of sedimentable acid hydrolases of intact granules obtained from disrupted polymorphonuclear leucocytes. 4. Cytochalasin B (2-10,ug/ml) causes a time-and dose-dependent release ofmouse peritoneal macrophage acid hydrolases. 5. This effect is selective at all doses of cytochalasin B used, since no release of lactate dehydrogenase, malate dehydrogenase and leucine 2-naphthylamidase was detected. 6. Treatment with cytochalasin B at doses of up to 10,ug/ml for as long as 72h did not significantly change the total activities of any of the enzymes measured. 7. The lack of toxicity of cytochalasin B was shown by dye-exclusion tests and its failure to release radioactive colloidal gold stored in secondary lysosomes.
The capacity of various cells to release selectively their lysosomal enzymes, almost certainly by exocytosis, has become apparent in recent years. This phenomenon has been observed in both physiological and pathological situations. The former is exemplified by the remodelling of bone induced by parathyroid hormone (Vaes, 1968) and the latter by the release of large amounts of acid protease from cultures of limbbone rudiments treated with complement-sufficient antiserum (Dingle et al., 1967) .
More recently selective exocytosis of acid hydrolases has been shown to be a concomitant of phagocytosis by polymorphonuclear leucocytes and macrophages (Hawkins & Peeters, 1971; Henson, 1971; Weissmann et al., 1971; Davies et al., 1973) . Woodin & Wieneke (1963) had shown that exocytosis of polymorphonuclear-leucocyte acid hydrolases could be induced by low doses ofretinol (vitamin A alcohol).
The biological properties of cytochalasin B were first described by Carter (1967) , who showed that this compound inhibits cell movement and brings about the formation of multinucleate cells or (in high doses) complete enucleation. These observations have been confirmed by others (Ridler & Smith, 1968 ; Krishnan & Raychaudhuri, 1969; Allison et al., 1971; Estensen, 1971; Gail & Boone, 1971; Krishnan, 1971; Prescott et al., 1971; Sanger et al., 1971; Spooner et al., 1971; Crawford et al., 1972) .
We now report that the disruption of cellular organization caused by cytochalasin B also results in the selective release of acid hydrolases. These experiments have been carried out with two kinds of Vol. 134 phagocytic cells, namely rabbit peritoneal-exudate polymorphonuclear leucocytes and the adherent population of cells, predominantly macrophages, obtained by lavage of the mouse peritoneal cavity. A preliminary account of some of this work has already been published .
Materials and Methods Materials
Cytochalasin B was obtained from Imperial Chemical Industries Ltd., Pharmaceuticals Division, Alderley Park, Macclesfield, Cheshire, U.K. The compound was dissolved at a concentration of 1 mg/ ml in dimethyl sulphoxide for experiments with polymorphonuclear leucocytes and suspended at a similar concentration in calf serum for experiments with mouse peritoneal cells.
Medium 199 was obtained from Grand Island Biological Co., Grand Island, N.Y., U.S.A., in powder form and reconstituted with deionized water. Calf serum was obtained from Tissue Culture Supplies Ltd., Slough, Bucks., U.K. All batches were heated at 56°C for 30min before use.
Crystalline synthetic all-trans-retinol, phenolphthalein glucuronic acid (10mM; pH7.0), o-nitrophenyl ,B-D-galactopyranoside, leucine 2-naphthylamide and glycogen (from oyster) were obtained from Sigma (London) Chemical Co. Ltd., London S.W.6, U.K. Heparin (5000 units/ml) was from Boots Pure Drug Co., Nottingham, U.K. Haemoglobin (acid protease substrate powder) was from Worthington 2 Chemical Corp., Freehold, N.J., U.S.A. Radioactive colloidal gold (specific radioactivity 4-12mCi/mg of Au; particle size up to 20nm) was obtained from The Radiochemical Centre, Amersham, Bucks., U.K.
Preparation of rabbit peritoneal-exudate polymorphonuclear leucocytes A 0.1 % (w/w) glycogen solution in 0.9% NaCl was incubated at 37°C for 24h before intraperitoneal injection of250ml/rabbit. Harvesting ofpolymorphonuclear leucocytes was carried out as previously described . The cells were washed three times in cold Hanks solution after collection and suspended at a final cell concentration of 25 x 106/ml.
Preparation of isolated polymorphonuclear-leucocyte lysosomes Polymorphonuclear leucocytes were washed and suspended in ice-cold 0.34M-sucrose containing 50 units of heparin/ml. The cells were then disrupted by repeated passage through a Millipore-filter assembly . Nuclear debris was sedimented by centrifugation at 400g and the milky supematant was used for measurement of lysosomal ability to sediment.
Preparation of mouse peritoneal cells
These cells were collected and cultured by following procedures initially described by Cohn & Benson (1965a) . Outbred Swiss mice (TO strain) were killed by ether anaesthesia. The abdomen of each animal was thoroughly swabbed with 70 % (v/v) ethanol and the skin deflected so as to expose fully the peritoneal wall. The peritoneum was lavaged by injection of 4ml of cold medium 199 containing 50% (v/v) of calf serum and gentle massage, followed immediately by withdrawal of all peritoneal fluid. The cell suspension thus obtained was counted and its cell concentration adjusted to 1 x 106 cells/ml. Portions (5ml) of these suspensions were distributed into plastic Petri dishes (Nunc, Jobling Laboratories Division, Stone, Staffs., U.K.) and cells allowed to adhere in an atmosphere containing 5 % CO2 in air at 37°C. After 34h the medium and non-adherent cells were aspirated and the attached cell sheet was thoroughly rinsed four times with phosphate-buffered saline, pH7 (Dulbecco's PBS 'A'; Dulbecco & Vogt, 1954 The culture medium was removed and centrifuged at 1000rev./min for 10min at 4°C in an MSE Mistral 6L centrifuge (no. 59548 swing-out head). The supernatant was removed and 3 ml was retained for enzyme assay. The pellet was resuspended in 2.Oml of 0.9% 1973 NaCl containing 0.1 % (v/v) of Triton X-100. Meanwhile the cell sheet was washed once with 4.Oml of 0.9% NaCl and then removed with 2.5ml of 0.9% NaCl containing 0.1 % (v/v) of Triton X-100. Complete cell removal was achieved by vigorous scraping with sterile silicone bungs. The medium and wash samples were made 0.1 % (v/v) with respect to Triton X-100 by addition of the required amount of 1 % (v/v) solution in 0.9 % NaCl. All samples were vigorously stirred at 4°C for 30min.
Enzyme assays Lactate dehydrogenase. This was assayed by determining the rate of oxidation of 9mM-NADH by measuring the changes in E340 in the presence of 0.3mM-pyruvate in 50mM-phosphate buffer, pH7.5, by following exactly the instructions issued with Biochemica Test Combination LDH-UV [Boehringer Corp. (London) Ltd., Ealing, London W.5, U.K.]. Samples were kept on ice and assayed on the same day, since the enzyme was found to be unstable if stored overnight.
,3-Glucuronidase. This was assayed by the method of Talalay Acid protease. This was assayed by the method of Anson (1937) , the tyrosine content of the trichloroacetic acid supernatant being determined with FolinCiocalteu reagent.
Leucine 2-naphthylamidase. This activity was determined by the method of Goldbarg & Rutenberg (1958) as described by Davies et al. (1970) .
Malate dehydrogenase. This activity was determined by measurement of the changes in E340 when 12mM-NADH is oxidized to NAD+ during the conversion of oxaloacetate into malate. The assay was carried out with materials contained in Biochemica Boehringer MDH Test Pack by following exactly the manufacturer's instructions.
Dye-exclusion tests
Culture medium was removed and replaced with a 0.1 % solution of Trypan Blue. The cultures were then incubated at 37°C for 1 h, at which time the Trypan Blue was removed and replaced by 0.9% NaCl. The number of cells taking up dye was measured in a field containing 400 cells. Results Effect of cytochalasin B on retinol-induced release of polymorphonuclear-leucocyte enzymes Fig. 1 shows that increasing concentrations of retinol induce a progressive release of,B-galactosidase. In the presence of cytochalasin B (10,ug/ml) enzyme release is significantly (P<0.01) increased at all concentrations of retinol used. Similar findings were obtained when the release of another lysosomal hydrolase, namely ,-glucuronidase, was measured (Table 1) . Fig. 2 shows that cytochalasin B fails to increase the release of lactate dehydrogenase induced by retinol at doses of 50,ug/ml and above. This implies that cytochalasin B disrupts cellular organization in such a way that extrusion of lysosomal hydrolases isenhancedduring the 30minperiod, at the end of which enzyme release was measured.
Effect of cytochalasin B on the ability to sediment of the lysosomes obtainedfrom disruptedpolymorphonuclear leucocytes Cytochalasin B, in concentrations from 2 to 50,ug/ ml, fails to influence the ability to sediment of isolated polymorphonuclear-leucocyte lysosomes. Table 2 shows that there are no significant changes in the release of ,B-glucuronidase and N-acetyl-fl-D-glucosaminidase in samples incubated for 30min at 37°C with cytochalasin B compared with controls incubated with solvent only.
In marked contrast samples incubated with 0.1 % Triton X-100 showed an immediate loss of turbidity, normally associated with intact lysosomes. This was accompanied by the release of a large amount of acid hydrolase into the 20000g supernatant. Therefore it seems clear that the increased loss ofacid hydrolases from polymorphonuclear leucocytes induced by cytochalasin B is not due to a direct labilization of lysosomal membranes.
Release of mouse peritoneal-macrophage acid hydrolases by cytochalasin B Temple et al. (1973) reported that guinea-pig peritoneal-exudate cells incubated with chicken erythrocytes coated with specific antibody release a large proportion of their acid hydrolases in the presence of cytochalasin B during a period of 5h. This release is selective, since lactate dehydrogenase loss is not increased. In the present experiments the cells were not exposed to a phagocytic stimulus, and it is clear from Fig. 3 that the release of fi-glucuronidase is delayed for at least 24h after the addition Vol. 134 of cytochalasin B. Between 24 and 72h large amounts of ,-glucuronidase and fi-galactosidase are released from the cells into the culture medium. The amount of enzyme released is dependent on the dose of cytochalasin B. Table 3 shows that after 72h increasing doses of cytochalasin B induce the release of increasing amounts of ,B-glucuronidase into the culture medium.
Effect of cytochalasin B on enzyme activities in macrophage cultures
Despite the major redistribution ofenzyme activity the total amount of enzyme was not significantly changed (Table 4) . Further evidence that cell viability was not compromised is provided in Table 4 . This shows that activities of two non-lysosomal enzymes, namely lactate dehydrogenase and leucine 2-naphthylamidase, in macrophage culture exposed to increasing concentrations of cytochalasin B for 72h are not significantly changed. Moreover cytochalasin B (10,ug/ml) did not affect the activity of malate dehydrogenase over a 72h incubation period (Table   4 ).
In marked contrast with our results with acid hydrolases we were unable to detect any lactate dehydrogenase, leucine 2-naphthylamidase and malate dehydrogenase activities in the culture medium in any of the experiments described above. However, we do not consider that this constitutes good evidence of the lack of toxicity of cytochalasin B. Both lactate dehydrogenase and malate dehydrogenase are unstable if released from cells by detergent treatment, so that small quantities released over prolonged timeintervals would not be detectable. The calfserum used in these experiments also contains non-specific NADH-oxidizing activity that would further mask small quantities of enzyme activity. Calf serum also contains leucine 2-naphthylamidase activity, and this prevents detection of low amounts of released intracellular enzyme. We therefore carried out more definitive tests for cytotoxicity, which we describe below.
Dye-exclusion tests
In view of the marked effects of cytochalasin B on both morphological and biochemical aspects of macrophage function, it is important to exclude nonspecific toxic effects of the drug. No significant differences in the number of cells taking up Trypan Blue Time (h) Fig. 4 . Effect of cytochalasin B (10,ug/ml) on release of radioactivity from macrophage cultures prelabelled with radioactive colloidal gold Each plate was incubated with radioactive colloidal gold (0.5,uCi) for 4h at 37'C before exposure to cytochalasin B. At 24h intervals up to 72h plates were examined for release of radioactive label and fl-glucuronidase into the culture medium: percentage of radioactivity remaining in control (A) and cytochalasin B-treated (A) cells; percentage of ,B-glucuronidase released into culture medium in control (o) and cytochalasin B-treated (U) cells.
were seen between control and cytochalasin Btreated cultures, indicating that the drug is not toxic. Both in control cultures and at all concentrations of cytochalasin B more than 95 % of the cells excluded Trypan Blue.
Retention of radioactive colloidal gold Cohn (1968) showed that macrophages accumulate colloidal gold in secondary lysosomes in a form not readily released (Cohn & Benson, 1965b) . We have confirmed this observation with radioactive gold, and Fig. 4 shows that macrophages labelled for 4h before exposure to cytochalasin B for 72h lose less than 5 % of the label during this time. In marked contrast large quantities of f-glucuronidase are released from treated cultures during this time (Fig. 4) .
Haswell, unpublished work) have established that macrophages accumulate radioactive gold in a timeand temperature-dependent manner.
Discussion
The capacity ofphagocytic cells to release selectively acid hydrolases under certain conditions has attracted attention recently because of the possible importance of this phenomenon in the mediation of various types oftissue damage involving polymorphoVol. 134 nuclear leucocytes (Cochrane, 1968) and macrophages (Page et al., 1972) . Such release has been found to accompany phagocytosis by macrophages ) and polymorphonuclear leucocytes Henson, 1971; Hawkins & Peeters, 1971) . Our group has shown elsewhere that this type of selective release is stimulated by cytochalasin B in both polymorphonuclear leucocytes and peritoneal macrophages (Temple et al., 1973) when these cells are presented with a phagocytic stimulus. The experiments described in the present paper show that cytochalasin B also causes the selective release of acid hydrolases from these cells in the absence of a phagocytic stimulus. In polymorphonuclear leucocytes treated with cytochalasin B phagocytosis of bacteria is completely inhibited, and electron microscopy shows that lysosomes accumulate in a position immediately subjacent to the plasma membrane sites at which bacterial attachment occurs . In macrophage cultures treated with cytochalasin B for 72h and then allowed to recover for 3 h the cells regain their normal shape, but lysosomes are distributed throughout the peripheral cytoplasm, in contrast with their perinuclear position in untreated cells (P. Davies, A. C. Allison & A. D. Haswell, unpublished work) . Therefore it is clear that the biochemical findings reported in this present paper have distinct morphological correlates. 39 0t Davies et al. (1973) have postulated that cytochalasin B exerts its effect by interfering with the function of a contractile microfilament system that normally plays a part in the maintenance of cellular organization, including the prevention of lysosomal access to the plasma membrane. This function is emphasized by the observation that microfilaments form a continuous meshwork around the periphery of phagocytic cells (Allison et al., 1971) .
The effects of cytochalasin B on the lysosomal systems of both polymorphonuclear leucocytes and macrophages occur without loss of cell viability. The augmentation of the effects of low doses of retinol in releasing acid hydrolases from polymorphonuclear leucocytes by cytochalasin B occurs in the absence of the release of lactate dehydrogenase. Moreover, at concentrations of retinol which cause cell lysis, as indicated by lactate dehydrogenase release, cytochalasin B gives acid hydrolase release that is superimposed on that obtained with retinol alone while having no effect on the release of lactate dehydrogenase. In macrophages exposed to cytochalasin B for 72h at doses tp to 1O,g/ml there was no detectable loss of non-lysosomal enzymes into the culture medium, nor any change in their intracellular activities. In a minority of our experiments the release of acid hydrolases was paralleled by an increase in the total activities of the various lysosomal hydrolases measured. This is reminiscent of the findings obtained by Dingle et al. (1967) , who showed that the release of acid protease from embryonic limb-bone cultures was accompanied by an increase in total enzyme activities. It is also noteworthy that there is a marked, though not statistically significant, increase in the activity of leucine 2-naphthylamidase in cultures exposed to cytochalasin B (Table 5 ). The determination of the activity of an enzyme at any given time is only a crude indicator of the behaviour of that enzyme in the cultures, since it does not take into account the turnover of the enzyme within the cell and the decay of activity after release into the extracellular environment. More sensitive methods for detection of enzyme activity and turnover should yield useful information on these points. Others have reported on the lack of toxicity of cytochalasin B and its effects on RNA, DNA, phospholipid (Estensen, 1971) and protein synthesis (Estensen, 1971; Parkhouse & Allison, 1972) . Cytochalasin B has, however, been shown to inhibit glucose transport in several cell types at low concentrations (Zigmond & Hirsch, 1972a,b; Estensen & Plagemann, 1972; Kletzien et al., 1972; Mizel & Wilson, 1972) . The significance of this inhibition to the biological effects of cytochalasin B is uncertain, especially since micropinocytosis, a possible entry route for glucose, is unaffected by cytochalasin B in macrophages (Wills et al., 1972) .
The failure of cytochalasin B to release radioactive colloidal gold from secondary lysosomes although large quantities of fl-glucuronidase are being released deserves comment. This differential release may occur in several ways: (a) the gold may be tightly bound to a lysosomal component, such as that described by Dingle & Barrett (1969) , which is not released during the loss of acid hydrolases; (b) the nature of the experiment described in the present paper does not exclude the possibility that the figlucuronidase was released from a population of lysosomes formed after labelling with the radioactive gold; (c) the ,B-glucuronidase may have been released from a non-lysosomal site such as the endoplasmic reticulum (Fishman et al., 1969) . Although exocytosis seems to be the most likely route of acid hydrolase release in cytochalasin B-treated polymorphonuclear leucocytes and macrophages, we only have morphological evidence for this route of release in the former cell type when presented with a phagocytic stimulus . No information is available as to whether cytochalasin B has similar effects on the lysosomal system of non-phagocytic cells. Effects of cytochalasin B on induced release of other packaged secretory products are variable. As reviewed by Allison (1973) , cytochalasin B in several systems inhibits such release, whereas in others it increases release, e.g. glucoseinduced discharge of insulin from isolated rat pancreatic islet cells (Orci et al., 1972) and antigeninduced release of histamine from sensitized leucocytes (Colten & Gabbay, 1972; Orr etal., 1972) . These apparently conflicting results can perhaps be reconciled by supposing that a microfilament network normally keeps granules away from the plasma membrane, and that either relaxation of this network by cytochalasin B, or induced contraction of the microfilament system into bundles leaving spaces between them, may allow the granules to gain access to the plasma membrane and be discharged. Whether cytochalasin B increases or inhibits release will then depend on a delicate balance that varies according to the cell type and experimental conditions used.
It is clear that cytochalasin B promotes the release of acid hydrolases from phagocytic cells under a variety of conditions. This occurs rapidly in the presence of a phagocytic stimulus Temple et al., 1973) and under conditions where membranes are labilized by substances such as retinol. In the absence of any stimulus release occurs to a smaller extent in polymorphonuclear leucocytes (Table 1 and Fig. 1 ) and more slowly in macrophages (Fig. 3) . The use of cytochalasin B to induce selective release of acid hydrolases from phagocytic cells may help to elucidate the role of these enzymes in tissue damage in which these cells are involved. Moreover it may facilitate analyses of other cells in which selective release of acid hydrolases or other products plays a role in their function in health and disease.
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